Download EPISODIC SOAP NOTE FINAL STUDY SHEET 2026 COMPLETE RESPONSES A+ and more Exams Nursing in PDF only on Docsity!
EPISODIC SOAP NOTE FINAL STUDY SHEET
2026 COMPLETE RESPONSES A+
◉ Who is authorized to prescribe controlled drugs and substances in most jurisdictions in Canada? Answer: Nurse Practitioners (NPs). ◉ What is the responsibility of Nurse Practitioners regarding their scope of practice? Answer: Each NP must know the limitations and scope dictated by their Regulatory Body and employer. ◉ What is the significance of the Canadian Council of Registered Nurse Regulators (CCRNR)? Answer: It collaborates with various partners to standardize education and scope of practice for NPs across Canada. ◉ What percentage increase in opioid-related deaths was noted in Canada? Answer: 40% increase. ◉ What is a key principle when prescribing controlled drugs and substances? Answer: All options for non-CDS strategies should be exhausted before considering CDS.
◉ What is the recommended approach to dosing when starting opioid therapy? Answer: Start at low doses and avoid high daily doses, ideally under 90 mg morphine equivalent dose (MED). ◉ What should be done before initiating opioid therapy? Answer: Obtain informed consent and engage in shared decision-making with the patient. ◉ What is the role of the health care provider in relation to prescribing CDS? Answer: The role often includes de-prescribing and tapering high-dose opioid therapy if necessary. ◉ What factors should be assessed before prescribing CDS? Answer: Client's medical, psychosocial, and family history, as well as their treatment goals. ◉ What is the purpose of a prescription monitoring system? Answer: To monitor the prescription of controlled drugs and substances and prevent misuse. ◉ What is the importance of clear communication with clients when prescribing CDS? Answer: To explain the risks of the medication and the consequences of misuse.
◉ What is the significance of informed consent in opioid therapy? Answer: It ensures patients are aware of potential benefits, risks, and complications before starting treatment. ◉ What is the impact of opioid prescribing on Canadian health? Answer: It has led to increasing concerns regarding prescription misuse and opioid-related deaths. ◉ What is the responsibility of NPs regarding compliance? Answer: NPs must practice in compliance with relevant legislation, standards of practice, and employer policies. ◉ What is the importance of assessing the risks of misuse of CDS? Answer: To protect clients from potential misuse and prevent provider exposure to legal liability. ◉ What should be included in the evaluation of evidence supporting the efficacy of CDS? Answer: Tools that assess the strength of evidence. ◉ What is the role of health care providers in relation to tapering medications? Answer: They may need to taper medications, especially when clients use a combination of controlled drugs.
◉ What is the goal of the College of Family Physicians of Canada regarding opioid therapy? Answer: To optimize non-opioid therapies before considering opioids. ◉ What regulatory amendments came into effect in March 2022 regarding tramadol? Answer: Tramadol is now listed under the narcotic control regulations with similar controls as other opioids. ◉ What is the role of the jurisdictional regulatory body in nursing practice? Answer: It sets the rules governing nursing practice, which can vary among provinces and territories. ◉ What are the requirements for Nurse Practitioners (NPs) in British Columbia to prescribe controlled substances? Answer: Prescribing NPs must meet specific BCCNP requirements and register with the provincial PharmaNet program. ◉ What is the prescribing standard for NPs in Alberta regarding controlled substances? Answer: NPs must comply with the Triplicate Prescription Program (TPP) as outlined by CARNA. ◉ What is the prescription guideline for NPs in Saskatchewan? Answer: NPs can prescribe controlled drugs and substances as outlined in their Prescribing Guideline and participate in the Prescription Review Program.
◉ What does the Yukon follow for NP prescribing? Answer: NPs prescribe according to the Controlled Drugs and Substances Act (CDSA) and its regulations. ◉ What is the fatality rate of opioid-related deaths among First Nations compared to the general population? Answer: First Nations have 3-5 times higher fatality rates from opioid-related deaths. ◉ What demographic is most affected by opioid-related deaths in Canada? Answer: 74% of opioid-related deaths involve males, with a peak age of 30-39 years. ◉ What percentage of opioid-related deaths in 2016 involved poly- substance use? Answer: 82% of deaths involved poly-substance use. ◉ What was the involvement rate of fentanyl in opioid-related deaths in Canada in 2016? Answer: Fentanyl was involved in 53% of deaths in 2016. ◉ What are some risk factors for opioid-related fatalities? Answer: Poly-substance use, prior prescriptions, low-mid-income neighborhoods, unstable housing, and correctional settings.
◉ What is the recommended approach for Family Nurse Practitioners (FNPs) regarding opioid exposure? Answer: Screen for opioid exposure, mental health comorbidity, and social risk. ◉ What is the first-line treatment for Opioid Use Disorder (OUD)? Answer: Buprenorphine-naloxone is preferred for safety; methadone is an alternative. ◉ What should FNPs prioritize in pain management for chronic non- cancer pain? Answer: Non-opioid pharmacologic options and psychological therapies. ◉ What is the recommendation for prescribing opioids according to clinical guidelines? Answer: Prefer non-opioid options, use the lowest effective dose, and avoid exceeding 50 mg MED/day. ◉ What is the significance of harm reduction in opioid management? Answer: Provide naloxone kits, safe-use education, and referrals to community programs. ◉ What is the focus of equity in opioid prescribing? Answer: Support First Nations, homeless, and incarcerated populations with culturally safe care.
◉ What are some responsibilities outlined for manufacturers and prescribers under the CDS? Answer: They have reporting responsibilities regarding controlled drugs and substances. ◉ What is a key benefit of drug monitoring programs? Answer: To reduce inappropriate or duplicate prescriptions for controlled drugs. ◉ What percentage decrease in inappropriate opioid prescriptions was observed in British Columbia after implementing the PharmNet system? Answer: 32.8% decrease. ◉ What ethical dilemma is associated with prescribing controlled drugs for chronic pain? Answer: Balancing the need for pain management against the risk of opioid misuse. ◉ What is the role of the WHO regarding pain management? Answer: They developed guidelines for cancer pain management, including an analgesic ladder. ◉ What is the highest level of evidence for clinical practice guidelines according to the Oxford Centre for Evidence-Based Medicine? Answer: Evidence obtained from a systematic review of all relevant randomized-controlled trials (RCTs).
◉ What is a significant trend observed in opioid toxicity deaths in Canada from January 2016 to March 2025? Answer: 53, apparent opioid toxicity deaths reported. ◉ What demographic is most affected by opioid toxicity deaths in early 2025? Answer: Approximately 73% male, primarily ages 40-
◉ What percentage of opioid deaths in 2025 involved fentanyl? Answer: 63%. ◉ What is the implication of polysubstance use in overdose cases? Answer: Polysubstance use (opioid + stimulant) is common, necessitating mixed exposure assessments. ◉ What should family nurse practitioners (FNPs) prioritize in high- risk populations? Answer: Awareness of middle-aged adults, especially males, in overdose data. ◉ What is a recommended practice for opioid prescribing in communities with high illicit drug risks? Answer: Caution in prescribing decisions and distribution of naloxone kits.
◉ What is the significance of the NP-eResource developed by the Canadian Association of Schools of Nursing? Answer: It provides a summary of Prescription Control Programs in each province. ◉ What is a key finding regarding opioid treatment admissions in states with and without prescription monitoring programs? Answer: Opioid treatment admissions were 1.9% higher per quarter in states without monitoring programs. ◉ What is the impact of drug diversion on patient safety? Answer: It can lead to increased harm to patients and others. ◉ What is the ethical concern regarding the under-treatment of pain? Answer: It can be harmful to the patient. ◉ What is the role of intersectoral coordination in overdose response? Answer: To liaise with emergency services and addiction services for comprehensive care. ◉ What is the importance of the Agree tool in clinical practice guidelines? Answer: It helps assess the rigor of the evidence underpinning recommendations.
◉ What does the CDSA organize substances into? Answer: Schedules (I through VI, plus additional regulatory schedules) based on risk, medical use, and regulatory oversight. ◉ Which substances are included in Schedule I? Answer: Many opioids, their derivatives, and analogues. ◉ Who has the authority to modify the schedules of substances under the CDSA? Answer: The Governor in Council (federal Cabinet). ◉ What does the CDSA authorize regarding controlled substances? Answer: The creation of regulations for licensing, permits, exemptions, record-keeping, and reporting. ◉ What are exemptions under the CDSA? Answer: Possibilities for medical, scientific, or research uses under conditions established by regulation. ◉ What does the CDSA regulate regarding precursor chemicals? Answer: It regulates substances that can be used to make controlled substances and designated devices for their manufacture. ◉ What actions can peace officers take under the CDSA? Answer: They may seize controlled substances, precursors, or devices if they suspect illicit activity.
◉ What is required for possession of narcotics under the Narcotic Control Regulations? Answer: Possession is regulated unless authorized under the Act or these Regulations. ◉ What must one hold to distribute, manufacture, import, or export narcotics? Answer: A dealer's licence. ◉ What must be reported regarding narcotics according to the regulations? Answer: Thefts, losses, or unusual transactions must be reported to the proper authorities. ◉ What are the record-keeping requirements for dealers and pharmacists? Answer: They must maintain logs of narcotics received, dispensed, sold, or transferred for regulatory inspection. ◉ What obligations do pharmacists have under the Narcotic Control Regulations? Answer: They must comply with obligations regarding sale, dispensing, and record-keeping of narcotics. ◉ What conditions must practitioners meet to administer or prescribe narcotics? Answer: They must be authorized under the Act and comply with regulatory conditions.
◉ What specific uses of narcotics are permitted for hospitals? Answer: For in-patient care and emergencies, with their own record and reporting rules. ◉ Under which act are the Narcotic Control Regulations issued? Answer: Controlled Drugs and Substances Act (CDSA). ◉ What must practitioners comply with to prescribe narcotics? Answer: Regulatory conditions including formats, record-keeping, and limits. ◉ What is required for record-keeping regarding narcotics? Answer: Maintain accurate logs of narcotic prescriptions and inventory. ◉ What must be reported regarding narcotics? Answer: Losses, thefts, and unusual transactions. ◉ What are the conditions for the sale of narcotics? Answer: Prescribers must adhere to specific rules about how narcotics are sold or dispensed. ◉ What does the Schedule in the Narcotic Control Regulations list? Answer: Specific substances considered narcotics under these regulations.
◉ What is the penalty for unlawful sale or distribution of cannabis? Answer: Penalties can range from fines to up to 14 years' imprisonment for serious violations. ◉ What are the restrictions on advertising cannabis? Answer: No promotion appealing to youth; only factual information and brand- preference promotion for adults. ◉ What is the legal possession limit for adults under the Cannabis Act? Answer: 30 grams of dried cannabis or equivalent. ◉ What is allowed regarding home cultivation of cannabis? Answer: Up to 4 plants per household for personal use, subject to provincial rules. ◉ What must be included on cannabis packaging? Answer: Health warnings, THC/CBD content, and excise stamps. ◉ What is the purpose of the national cannabis tracking system? Answer: To prevent diversion to the illicit market and ensure traceability from seed to sale. ◉ What are the reporting obligations for narcotics? Answer: Practitioners must report thefts, losses, and suspicious transactions.
◉ What are the implications of the amendments to the Narcotic Control Regulations? Answer: They reflect updates to the regulations, with the last amendment noted on 2024- 06 - 05. ◉ What is the relevance of the 'Practitioner privileges' in narcotic regulations? Answer: They define the conditions under which practitioners may prescribe, administer, or dispense narcotics. ◉ What does 'audit readiness' mean in the context of narcotic regulations? Answer: Being prepared to demonstrate compliance with record-keeping and reporting obligations. ◉ Why is it important to know the schedule of narcotics? Answer: To understand which substances are subject to stricter regulatory rules. ◉ What are the obligations of hospitals under the Narcotic Control Regulations? Answer: Special rules apply for the in-hospital use of narcotics, relevant for inpatient care. ◉ What are ticketable offences? Answer: Minor offences that may be treated as ticketable instead of criminal charges. ◉ What do Administrative Monetary Penalties (AMPs) apply to? Answer: Regulatory non-compliance such as labelling or advertising infractions.
